Inhibition of murine hepatic cytochrome P450 activities by natural and synthetic phenolic compounds

被引:109
|
作者
Baer-Dubowska, W [1 ]
Szaefer, H [1 ]
Krajka-Kuzniak, V [1 ]
机构
[1] K Marcinkowski Univ Med Sci, Dept Pharmaceut Biochem, PL-60780 Poznan, Poland
关键词
D O I
10.1080/004982598239155
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The effect of the phenolic compounds protocatechuic acid, chlorogenic acid, tannic acid, gallates and silybin on ethoxyresorufin O-dealkylase (CYP1A1), methoxyresorufin O-dealkylase (CYP1A2) and pentoxy-O-dealkylase (CYP2B) was examined in mouse liver microsomes from induced animals. 2. All compounds tested could inhibit cytochrome P450-mediated enzyme activities, but to different extents. Tannic acid was the most potent inhibitor, especially toward EROD activity with an IC50 = 2.6 mu M. Synthetic dodecyl gallate was also relatively selective toward this enzyme activity with an IC50 = 120 mu M. 3. Protocatechuic acid, chlorogenic and silybin were more selective towards PROD and MROD activities. Their relative inhibitory potency for PROD activity was as follows: chlorogenic acid > protocatechuic acid > silybin > dodecyl gallate > propyl gallate. Protocatechuic acid was a more effective inhibitor of MROD activity than chlorogenic acid, and propyl gallate more effective than dodecyl gallate. Thus, no clear structure-activity or selectivity relationship was observed. 4. Analysis of the kinetics of inhibition revealed that the inhibition in most cases was non-competitive in nature.
引用
收藏
页码:735 / 743
页数:9
相关论文
共 50 条
  • [41] Cytochrome P450 Monooxygenases in Biotechnology and Synthetic Biology
    Urlacher, Vlada B.
    Girhard, Marco
    TRENDS IN BIOTECHNOLOGY, 2019, 37 (08) : 882 - 897
  • [42] Assessment of Rat Hepatic Cytochrome P450 Induction and Inhibition Potential of Chlorogenic Acid
    Subash, Sandhya
    Seervi, M.
    Iyer, K.
    Damre, Anagha
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2011, 45 (01) : 32 - 39
  • [43] Assessment of inhibition of porcine hepatic cytochrome P450 enzymes by 48 commercial drugs
    Hu, Steven X.
    Mazur, Chase A.
    Feenstra, Kenneth L.
    Lorenz, Julie K.
    Merritt, Dawn A.
    VETERINARY JOURNAL, 2016, 211 : 26 - 31
  • [44] Differential regulation of hepatic cytochrome P450 monooxygenases
    Sindhu, RK
    Roberts, CK
    FASEB JOURNAL, 2006, 20 (04): : A459 - A460
  • [45] An evaluation of the cytochrome P450 inhibition potential of selected pesticides in human hepatic microsomes
    Abass, Khaled
    Turpeinen, Miia
    Pelkonen, Olavi
    JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART B-PESTICIDES FOOD CONTAMINANTS AND AGRICULTURAL WASTES, 2009, 44 (06) : 553 - 563
  • [46] Measurement of cytochrome P450 and NADPH–cytochrome P450 reductase
    F Peter Guengerich
    Martha V Martin
    Christal D Sohl
    Qian Cheng
    Nature Protocols, 2009, 4 : 1245 - 1251
  • [47] New synthetic models of cytochrome P450: How different are they from the natural species?
    Kozuch, S
    Leifels, T
    Meyer, D
    Sbaragli, L
    Shaik, S
    Woggon, WD
    SYNLETT, 2005, (04) : 675 - 684
  • [48] Inhibitory mechanism of isoniazid on cytochrome P450 activities
    Nishimura, Y
    Kurata, N
    Li, H
    Iwase, M
    Yasuhara, H
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 186P - 186P
  • [49] No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug
    Niwa, T
    Inoue, S
    Shiraga, T
    Takagi, A
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (01) : 188 - 191
  • [50] Validated assays for human cytochrome P450 activities
    Walsky, RL
    Obach, RS
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (06) : 647 - 660